SYS-CON MEDIA Authors: Michael Bushong, PR.com Newswire, David Smith, Tim Crawford, Kevin Benedict

News Feed Item

Lenstatin™ Introduces The World's First Nutritional Supplement For Lens Metabolism Support In Patients With Early Cataract Formation

WILMINGTON, N.C., Jan. 20, 2014  /PRNewswire/ -- Lenstatin™ LLC announces worldwide introduction of the very first nutritional supplement specifically formulated to support healthy lens metabolism for patients with early cataract formation. Lenstatin contains a Unique Proprietary Antioxidant Blend of micronutrients with anti-cataractogenic activity, the exact formula of which is not reproduced by any other vitamin preparation.

(Photo: http://photos.prnewswire.com/prnh/20140120/CL49313)

An emerging body of scientific evidence suggests that specific antioxidants have beneficial effects on human lens metabolism as well as anti-cataractogenic activity. In addition, the general public has an increasingly acute interest in wellness and nutraceutical strategies which are based on scientific data and which may have beneficial effects in inhibiting the progression of chronic pre-surgical conditions. Lenstatin is formulated specifically to fulfill the role of targeted nutritional support in patients with early non-surgical cataracts.

According to Scott W. Tunis MD FACS, a Board Certified Ophthalmologist and Fellow of The American College of Surgeons with over 30 years experience performing more than 25,000 cataract operations,

Dr. Tunis states, "Lenstatin should not replace ongoing professional examination, treatment or surgery, maintaining a healthy lifestyle and diet, and avoiding prolonged UV exposure. However in the setting of early cataracts patients should also consider initiating targeted lens health and anti-cataract nutritional support with Lenstatin."

For more information visit www.Lenstatin.com.

About Lenstatin LLC
Founded by Scott W. Tunis MD FACS in 2013 to develop ocular disease specific nutraceuticals. Dr. Tunis is a Board Certified Fellow of The American Academy of Ophthalmology, a Fellow of The American College of Surgeons, a member of The American Society of Cataract and Refractive Surgery, and holder of two United States Patents on eye surgery technology.

SOURCE Lenstatin LLC

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.